First Light Asset Management »

Cidara Therapeutics shares owned by First Light Asset Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $28M 293k 95.76
2025-06-30 $8.8M 181k 48.71

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Performant Healthcare Common Stocks (PHLT)
Centessa Pharmaceuticals Common Stocks (CNTA)
Neogenomics Common Stocks (NEO)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Health Catalyst Common Stocks (HCAT)
Palvella Therapeutics Common Stocks (PVLA)
Twist Bioscience Corporation Common Stocks (TWST)
Lenz Therapeutics Common Stocks (LENZ)
Organogenesis Holdings Common Stocks (ORGO)
Atricure Common Stocks (ATRC)
Anaptys Bio Common Stocks (ANAB)
Si-bone Common Stocks (SIBN)
Cidara Therapeutics Common Stocks (CDTX)

View all positions for First Light Asset Management

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics